News Focus
News Focus
icon url

operating_line

11/29/18 7:16 AM

#8113 RE: Scherzman #8112

With higher revenues achieved in 2018 than for 2017 and lower operating expenses highlighted for the Yangling region, do you expect any EPS growth for 2018 compared to EPS=0.51 for 2017?

The title of the latest article suggests attention is for 2019:
"Growth Plans in Place for Strong 2019"

http://kiwabiotech.com/kiwa/kiwa-bio-tech-announces-record-third-quarter-2018-financial-results-and-growth-plans-in-place-for-strong-2019/